Show simple item record

dc.creatorRobajac, Dragana
dc.creatorVanhooren, Valerie
dc.creatorMasnikosa, Romana
dc.creatorMiković, Zeljko
dc.creatorMandić, Vesna
dc.creatorLibert, Claude
dc.creatorNedić, Olgica
dc.date.accessioned2018-03-01T16:41:37Z
dc.date.available2018-03-01T16:41:37Z
dc.date.issued2016
dc.identifier.issn0014-4800
dc.identifier.issn1096-0945
dc.identifier.urihttps://vinar.vin.bg.ac.rs/handle/123456789/934
dc.description.abstractPosttranslational modifications (PTM) which accompany pathological conditions affect protein structure, characteristics and modulate its activity. Glycosylation is one of the most frequent PTM influencing protein folding, localisation and function. Hypertension is a common gestational complication, which can lead to foetal growth restriction (IUGR) and even to foetal or maternal death. In this work we focused on the impact of preeclampsia complicated with IUGR on placental membrane N-glycome. Results have shown that preeclampsia reduced fucosylation of placental glycans, increased the appearance of paucimannosidic and mannosidic structures with lower number of mannose residues and decreased the amount of glycans with more mannose residues. Since preeclampsia is tightly connected to IUGR, glycosylation changes were investigated also on the functional membrane receptors responsible for growth: insulin receptor and the type 1 insulin-like growth factor receptor (IR and IGF1R). It was found that IR present in the IUGR placenta contained significantly less alpha 2,6-Sia. Therefore, glycans on placental membranes alter due to preeclampsia, but changes seen at the level of the entire N-glycome may be different from the changes detected at the level of a specific glycoprotein. The difference recorded due to pathology in one membrane molecule (IR) was not found in another homologous molecule (IGF1R). Thus, besides studying the glycosylation pattern of the entire placental membrane due to preeclampsia, it is inevitable to study directly glycoprotein of interest, as no general assumptions or extrapolations can be made. (C) 2015 Elsevier Inc All rights reserved.en
dc.publisherElsevier
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173042/RS//
dc.relationCOST Action [COST-STSM-CM1001-9130]
dc.rightsrestrictedAccessen
dc.sourceExperimental and Molecular Pathologyen
dc.subjectPreeclampsiaen
dc.subjectIUGRen
dc.subjectGlycosylationen
dc.subjectPlacental membraneen
dc.subjectDSA-FACEen
dc.subjectIRen
dc.subjectIGF1Ren
dc.titlePreeclampsia transforms membrane N-glycome in human placentaen
dc.typearticleen
dc.rights.licenseARR
dcterms.abstractВанхоорен, Валерие; Робајац, Драгана; Мандиц, Весна; Масникоса Романа; Недиц, Олгица; Либерт, Цлауде; Миковиц, Зељко;
dc.citation.volume100
dc.citation.issue1
dc.citation.spage26
dc.citation.epage30
dc.identifier.wos000369879100005
dc.identifier.doi10.1016/j.yexmp.2015.11.029
dc.citation.rankM21
dc.identifier.pmid26655437
dc.type.versionpublishedVersion
dc.identifier.scopus2-s2.0-84949575754


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record